Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;27(1):56-62.
doi: 10.1097/MED.0000000000000517.

Prader Willi syndrome: endocrine updates and new medical therapies

Rebecca M Harris  1 , Diane E J Stafford  2
Affiliations
Review

Prader Willi syndrome: endocrine updates and new medical therapies

Rebecca M Harris et al. Curr Opin Endocrinol Diabetes Obes. 2020 Feb.

Abstract

Purpose of review: Prader Willi syndrome is characterized not only by hyperphagia frequently resulting in obesity, but also by endocrine dysfunction across a variety of axes. This article reviews the most recent literature regarding possible causes of hyperphagia and the nature of endocrinopathies seen in Prader Willi syndrome, as well as current research into possible therapies.

Recent findings: Investigation into neurologic, metabolic and hormonal drivers of hyperphagia and obesity has revealed new insights and clarified underlying pathophysiology. Additional studies continue to elucidate the hormonal deficiencies seen in the syndrome, allowing for improvements in clinical care.

Summary: The underlying causes of the hyperphagia and progressive obesity frequently seen in Prader Willi Syndrome are largely unknown and likely multifactorial. Understanding the hormonal and metabolic drivers at work in PWS, as well as the nature of other hormonal dysfunction seen in the syndrome is necessary to guide current management and future research directions.

PubMed Disclaimer

References

    1. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med 2012; 14:10–26.
    1. Dykens EM, Roof E, Hunt-Hawkins H. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. J Child Psychol Psychiatry 2017; 58:64–74.
    1. Bakker NE, Lindberg A, Heissler J, et al. KIGS Steering Committee. Growth hormone treatment in children with Prader-Willi syndrome: three years of longitudinal data in prepubertal children and adult height data from the KIGS Database. J Clin Endocrinol Metab 2017; 102:1702–1711.
    1. Blanco-Hinojo L, Pujol J, Esteba-Castillo S, et al. Lack of response to disgusting food in the hypothalamus and related structures in Prader Willi syndrome. NeuroImage Clin 2019; 21:101662.
    1. Bochukova EG, Lawler K, Croizier S, et al. A Transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi syndrome. Cell Rep 2018; 22:3401–3408.

Publication types

MeSH terms

Substances